Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
3.48 EUR
357.60 M EUR
3.67 B EUR
40.53 M
About BIOMERIEUX
Sector
Industry
CEO
Pierre Boulud
Website
Headquarters
Marcy l'Etoile
Founded
1967
ISIN
FR0013280286
FIGI
BBG000QCJG62
bioMérieux SA engages in the provision of in vitro diagnostic solutions, which determine the source of disease and contamination. It develops testing, detection, and other laboratory system for the analysis of cancer, diseases, and infections caused by bacteria, virus, and fungi. The company was founded Alain Mérieux in 1963 and is headquartered in Marcy l'Etoile, France.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange BioMerieux stocks are traded under the ticker EYWN.
We've gathered analysts' opinions on BioMerieux future price: according to them, EYWN price has a max estimate of 130.00 EUR and a min estimate of 91.00 EUR. Watch EYWN chart and read a more detailed BioMerieux stock forecast: see what analysts think of BioMerieux and suggest that you do with its stocks.
EYWN reached its all-time high on Oct 12, 2020 with the price of 144.40 EUR, and its all-time low was 52.90 EUR and was reached on Jan 3, 2019. View more price dynamics on EYWN chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
Yes, you can track BioMerieux financials in yearly and quarterly reports right on TradingView.
BioMerieux is going to release the next earnings report on Mar 7, 2025. Keep track of upcoming events with our Earnings Calendar.
BioMerieux revenue for the last half-year amounts to 1.90 B EUR, despite the estimated figure of 1.88 B EUR. In the next half-year revenue is expected to reach 1.88 B EUR.
EYWN net income for the last half-year is 215.30 M EUR, while the previous report showed 196.00 M EUR of net income which accounts for 9.85% change. Track more BioMerieux financial stats to get the full picture.
Yes, EYWN dividends are paid annually. The last dividend per share was 0.85 EUR. As of today, Dividend Yield (TTM)% is 0.84%. Tracking BioMerieux dividends might help you take more informed decisions.
BioMerieux dividend yield was 0.84% in 2023, and payout ratio reached 28.08%. The year before the numbers were 0.87% and 22.16% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 14, 2024, the company has 14.65 K employees. See our rating of the largest employees — is BioMerieux on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BioMerieux EBITDA is 825.80 M EUR, and current EBITDA margin is 21.64%. See more stats in BioMerieux financial statements.
Like other stocks, EYWN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BioMerieux stock right from TradingView charts — choose your broker and connect to your account.